PATENT CLAIM ANALYSIS

Application Number: 15762878
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to a compound with formula (I) or a salt and/or a pharmaceutically acceptable solvate thereof, the method for preparing same as well as the uses thereof, in particular the therapeutic use thereof, mainly in the treatment of diseases associated with a hyperactivity of the endocannabinoid system.

Claim (Index 3):
The compound according to  claim 1 , wherein:\n R 1  and R 2 , which can be identical or different, represent a hydrogen atom or a COR 3 , SO 2 R 4  or CONR 5 R 6  group; R 3 , R 4  and R 5  independently represent an aryl group, preferably a phenyl, optionally substituted by a group selected from a halogen atom, preferably Cl or F, CF 3  and SO 2 R 12 , with R 12  representing a (C 1 -C 6 )alkyl group, preferably a methyl; and R 6  represents a hydrogen atom.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14370951', '14555290', '15771077', '14679846', '15263033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7511741507219357
- 35 USC 102 Novelty (BERT): 0.5137175557727369
- Combined Prediction Score: 0.7274284912270158
- Mean Citation Score: 269.005014
- Max Citation Score: 274.28796
- Similarity Product: 205.4088080613041

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test